日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/04/18 | 7,560 | 7,840 | 7,430 | 7,810 | +250 | +3.3% | 320,200 |
| 2018/04/17 | 7,540 | 7,630 | 7,520 | 7,560 | -10 | -0.1% | 183,700 |
| 2018/04/16 | 7,270 | 7,580 | 7,250 | 7,570 | +370 | +5.1% | 279,300 |
| 2018/04/13 | 7,350 | 7,390 | 7,140 | 7,200 | -90 | -1.2% | 208,800 |
| 2018/04/12 | 7,210 | 7,330 | 7,210 | 7,290 | +150 | +2.1% | 225,800 |
| 2018/04/11 | 7,330 | 7,350 | 7,120 | 7,140 | -270 | -3.6% | 328,300 |
| 2018/04/10 | 7,600 | 7,600 | 7,390 | 7,410 | -100 | -1.3% | 206,700 |
| 2018/04/09 | 7,430 | 7,560 | 7,390 | 7,510 | +80 | +1.1% | 240,300 |
| 2018/04/06 | 7,490 | 7,570 | 7,410 | 7,430 | -70 | -0.9% | 246,000 |
| 2018/04/05 | 7,350 | 7,540 | 7,330 | 7,500 | +230 | +3.2% | 261,000 |
| 2018/04/04 | 7,280 | 7,310 | 7,210 | 7,270 | -10 | -0.1% | 160,500 |
| 2018/04/03 | 6,970 | 7,320 | 6,950 | 7,280 | +220 | +3.1% | 339,800 |
| 2018/04/02 | 7,230 | 7,290 | 7,060 | 7,060 | -60 | -0.8% | 166,900 |
| 2018/03/30 | 7,200 | 7,210 | 7,070 | 7,120 | -20 | -0.3% | 179,400 |
| 2018/03/29 | 7,070 | 7,170 | 6,930 | 7,140 | +40 | +0.6% | 263,700 |
| 2018/03/28 | 7,120 | 7,180 | 7,050 | 7,100 | -110 | -1.5% | 211,600 |
| 2018/03/27 | 7,250 | 7,300 | 7,150 | 7,210 | +20 | +0.3% | 298,600 |
| 2018/03/26 | 6,870 | 7,190 | 6,870 | 7,190 | +370 | +5.4% | 453,400 |
| 2018/03/23 | 6,800 | 6,920 | 6,790 | 6,820 | -120 | -1.7% | 378,300 |
| 2018/03/22 | 6,870 | 6,960 | 6,800 | 6,940 | -30 | -0.4% | 412,400 |
| 2018/03/20 | 7,080 | 7,080 | 6,900 | 6,970 | +80 | +1.2% | 370,500 |
| 2018/03/19 | 6,950 | 6,970 | 6,780 | 6,890 | -170 | -2.4% | 313,700 |
| 2018/03/16 | 6,950 | 7,090 | 6,900 | 7,060 | +210 | +3.1% | 603,000 |
| 2018/03/15 | 6,870 | 6,960 | 6,830 | 6,850 | +50 | +0.7% | 359,700 |
| 2018/03/14 | 6,750 | 6,850 | 6,700 | 6,800 | +20 | +0.3% | 363,500 |
| 2018/03/13 | 6,690 | 6,790 | 6,670 | 6,780 | +50 | +0.7% | 256,800 |
| 2018/03/12 | 6,700 | 6,810 | 6,690 | 6,730 | +130 | +2% | 351,600 |
| 2018/03/09 | 6,710 | 6,710 | 6,590 | 6,600 | +90 | +1.4% | 524,900 |
| 2018/03/08 | 6,470 | 6,530 | 6,400 | 6,510 | +140 | +2.2% | 481,600 |
| 2018/03/07 | 6,140 | 6,400 | 6,130 | 6,370 | +170 | +2.7% | 535,700 |
| 2018/03/06 | 6,200 | 6,240 | 6,150 | 6,200 | +60 | +1% | 464,600 |
| 2018/03/05 | 5,940 | 6,170 | 5,930 | 6,140 | +160 | +2.7% | 577,800 |
| 2018/03/02 | 5,800 | 6,040 | 5,780 | 5,980 | +80 | +1.4% | 438,300 |
| 2018/03/01 | 5,960 | 5,960 | 5,860 | 5,900 | -120 | -2% | 308,300 |
| 2018/02/28 | 5,900 | 6,170 | 5,880 | 6,020 | +100 | +1.7% | 506,600 |
| 2018/02/27 | 6,030 | 6,030 | 5,820 | 5,920 | -50 | -0.8% | 485,100 |
| 2018/02/26 | 5,940 | 5,990 | 5,890 | 5,970 | +100 | +1.7% | 526,900 |
| 2018/02/23 | 5,870 | 5,920 | 5,800 | 5,870 | -40 | -0.7% | 651,500 |
| 2018/02/22 | 6,050 | 6,100 | 5,900 | 5,910 | -270 | -4.4% | 588,300 |
| 2018/02/21 | 6,200 | 6,280 | 5,980 | 6,180 | -110 | -1.7% | 620,100 |
| 2018/02/20 | 6,340 | 6,410 | 6,280 | 6,290 | -80 | -1.3% | 241,500 |
| 2018/02/19 | 6,280 | 6,400 | 6,260 | 6,370 | +120 | +1.9% | 212,100 |
| 2018/02/16 | 6,190 | 6,310 | 6,180 | 6,250 | +90 | +1.5% | 199,700 |
| 2018/02/15 | 6,080 | 6,210 | 6,080 | 6,160 | +100 | +1.7% | 304,000 |
| 2018/02/14 | 6,260 | 6,260 | 6,050 | 6,060 | -200 | -3.2% | 425,700 |
| 2018/02/13 | 6,420 | 6,430 | 6,230 | 6,260 | -130 | -2% | 414,400 |
| 2018/02/09 | 6,470 | 6,470 | 6,270 | 6,390 | -300 | -4.5% | 328,300 |
| 2018/02/08 | 6,750 | 6,780 | 6,650 | 6,690 | ±0 | ±0% | 292,000 |
| 2018/02/07 | 6,940 | 7,030 | 6,660 | 6,690 | -230 | -3.3% | 542,100 |
| 2018/02/06 | 6,960 | 7,000 | 6,760 | 6,920 | -440 | -6% | 334,500 |
1751～
1800
件表示中 / 3725件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 326,800円 | +8.0% | -15.3% | 3.79% | 9.18倍 | 0.89倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 久光薬 | 408,500円 | +5.8% | +1.2% | 2.94% | 13.55倍 | 1.08倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| ツムラ | 333,600円 | +3.8% | -19.9% | 4.08% | 10.84倍 | 0.83倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サワイＧＨＤ | 185,300円 | +5.9% | +684.6% | 2.97% | 12.29倍 | 1.23倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| ペプチド | 159,100円 | +5.0% | +1.5% | 0.00% | 13.61倍 | 3.62倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
